Novel compounds in the treatment of lung cancer: current and developing therapeutic agents.

about

Novel compounds in the treatment of lung cancer: current and developing therapeutic agents.

Item

http://www.wikidata.org/entity/Q36890658

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Novel compounds in the treatme ...... developing therapeutic agents.

@en

type

Item

label

Novel compounds in the treatme ...... developing therapeutic agents.

@en

prefLabel

Novel compounds in the treatme ...... developing therapeutic agents.

@en

P1476

Novel compounds in the treatme ...... developing therapeutic agents.

@en

P2093

Pokman Chan

http://www.w3.org/2001/XMLSchema#string

Rudi Bao

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Evaluation of EML4-ALK fusion proteins in non-small cell lung cancer using small molecule inhibitors

EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501

Nonlinear partial differential equations and applications: The mechanism of topoisomerase I poisoning by a camptothecin analog

BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

P304

21-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/JEP.S7804

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27186107

http://www.w3.org/2001/XMLSchema#string

P932

4863377

http://www.w3.org/2001/XMLSchema#string

Novel compounds in the treatment of lung cancer: current and developing therapeutic agents.

about

Novel compounds in the treatment of lung cancer: current and developing therapeutic agents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932